Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe

A. Matteelli, R. Centis, Giorgia Sulis, M. Tadolini

Research output: Contribution to journalArticle

Abstract

The number of international migrants worldwide has continued to grow rapidly over the past fifteen years and the trend is expected to continue, making the health matters associated with migration a crucial public health challenges faced by governments and societies. Multidrug-resistant tuberculosis is a paradigm of transmissible diseases that do not respect borders and poses a multifaceted and complex challenge on migrant health. The guiding principles for the health response are the respect of equity and human rights as well as the accurate analysis of epidemiological trends and determinants of TB in migrants. The action framework “Towards tuberculosis elimination: an action framework for low-incidence countries” includes regulations for cross border migration among the top eight interventions for TB elimination in low incidence countries. Political commitment is the essential requirement, and currently, the limiting factor, to draft regulations for cross-border collaboration, establish cross-border referral systems with contact tracing and information sharing. The e-platform TB Consilium hosted by European Respiratory Society in collaboration with World Health Organization – Euro is an example of a tool that can be used to exchange information for clinical management and surveillance. © 2016
Original languageEnglish
Pages (from-to)588-590
Number of pages3
JournalTravel Medicine and Infectious Disease
Volume14
Issue number6
DOIs
Publication statusPublished - 2016

Fingerprint

Tuberculosis
Health
Contact Tracing
Multidrug-Resistant Tuberculosis
Information Management
Information Dissemination
Incidence
Referral and Consultation
Public Health

Cite this

Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe. / Matteelli, A.; Centis, R.; Sulis, Giorgia; Tadolini, M.

In: Travel Medicine and Infectious Disease, Vol. 14, No. 6, 2016, p. 588-590.

Research output: Contribution to journalArticle

Matteelli, A. ; Centis, R. ; Sulis, Giorgia ; Tadolini, M. / Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe. In: Travel Medicine and Infectious Disease. 2016 ; Vol. 14, No. 6. pp. 588-590.
@article{5af3c81d4fc14e2eb7d582ca4b836652,
title = "Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe",
abstract = "The number of international migrants worldwide has continued to grow rapidly over the past fifteen years and the trend is expected to continue, making the health matters associated with migration a crucial public health challenges faced by governments and societies. Multidrug-resistant tuberculosis is a paradigm of transmissible diseases that do not respect borders and poses a multifaceted and complex challenge on migrant health. The guiding principles for the health response are the respect of equity and human rights as well as the accurate analysis of epidemiological trends and determinants of TB in migrants. The action framework “Towards tuberculosis elimination: an action framework for low-incidence countries” includes regulations for cross border migration among the top eight interventions for TB elimination in low incidence countries. Political commitment is the essential requirement, and currently, the limiting factor, to draft regulations for cross-border collaboration, establish cross-border referral systems with contact tracing and information sharing. The e-platform TB Consilium hosted by European Respiratory Society in collaboration with World Health Organization – Euro is an example of a tool that can be used to exchange information for clinical management and surveillance. {\circledC} 2016",
author = "A. Matteelli and R. Centis and Giorgia Sulis and M. Tadolini",
note = "Export Date: 14 March 2017 CODEN: TMIDA Correspondence Address: Matteelli, A.; Clinic of Infectious and Tropical Diseases, University of BresciaItaly; email: alberto.matteelli@unibs.it References: United Nations, Department of Economic and Social Affairs, Population Division, International migration report 2015: highlights (ST/ESA/SER.A/375) (2016), http://www.un.org/en/development/desa/population/migration/publications/migrationreport/docs/MigrationReport2015_Highlights.pdf, Available at: Accessed on 27 November 2016http://apps.who.int/iris/bitstream/10665/23533/1/A61_R17-en.pdf, World Health Assembly. Resolution WHA61.17 on the Health of Migrants, 24 May 2008. Available at: Accessed on 27 November 2016World Health Organization Global tuberculosis report, World health organization 2016 (2016), WHO/HTM/TB/2016.13 Geneva(2016) Tuberculosis surveillance and monitoring in Europe 2016, , European Centre for Disease Prevention and Control/WHO Regional office for Europe Stockholm; Falzon, D., Mirzayev, F., Wares, F., Baena, I.G., Zignol, M., Linh, N., Multidrug-resistant tuberculosis around the world: what progress has been made? (2015) Eur Respir J, 45, pp. 150-160; Jenkins, H.E., Crudu, V., Soltan, V., Ciobanu, A., Domente, L., Cohen, T., High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova (2014) Eur Respir J, 43, pp. 1132-1141; Hargreaves, S., L{\"o}nnroth, K., Nellums, L.B., Olaru, I.D., Nathavitharana, R.R., Norredam, M., Multidrug-resistant tuberculosis and migration to Europe (2016) Clin Microbiol Infect, , Sep 23; L{\"o}nnroth, K., Migliori, G.B., Abubakar, I., D'Ambrosio, L., De Vries, G., Diel, T., Towards tuberculosis elimination: an action framework for low-incidence countries (2015) Eur Respir J, 45, pp. 928-952; Pareek, M., Greenaway, C., Noori, T., Munoz, J., Zenner, D., The impact of migration on tuberculosis epidemiology and control in high-income countries: a review (2016) BMC Med, 14, p. 48; Dahle, U.R., Eldholm, V., Winje, B.A., Manns{\aa}ker, T., Heldal, E., Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country (2007) Am J Respir Crit Care Med, 176, pp. 930-935; Bernard, C., Brossier, F., Sougakoff, W., Veziris, N., Frechet-Jachym, M., Metivier, N., A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union (2013) Euro Surveill, 18 (33), p. 20555; Noeske, J., Foe, J.L., Kuaban, C., Cameroon's MDR-TB treatment programme jeopardised by cross-border migration (2016) Eur Respir J, 47 (2), pp. 684-686; Liu, Y., Painter, J.A., Posey, D.L., Cain, K.P., Weinberg, M.S., Maloney, S.A., Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States (2012) PLoS One, 7 (2), p. e32158; Codecasa, L.R., Ciconali, G., Mazzola, E., Ferrarese, M., Cirillo, D., Borroni, E., Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal (2015) Eur Respir J, 45, pp. 292-294; Matteelli, A., L{\"o}nnroth, K., Mosca, D., Getahun, H., Centis, R., D'Ambrosio, L., Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration (2016) EurRespir J, 47, pp. 686-688; Dara, M., Solovic, I., Goletti, D., Sotgiu, G., Centis, R., D'Ambrosio, L., Preventing and controlling tuberculosis among refugees in Europe: more is needed (2016) Eur Respir J, 48, pp. 272-274; Dara, M., de Colombani, P., Petrova-Benedict, R., Centis, R., Zellweger, J.P., Sandgren, A., Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement (2012) Eur Respir J, 40, pp. 1081-1090; D'Ambrosio, L., Tadolini, M., Centis, R., Duarte, R., Sotgiu, G., Aliberti, S., Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium (2015) Int J Infect Dis, 32, pp. 156-160; D'Ambrosio, L., Tadolini, M., Dupasquier, S., Tiberi, S., Centis, R., Dara, M., ERS/WHO Tuberculosis Consilium: reporting of the initial 10 cases (2014) Eur Respir J, 43 (1), pp. 286-289. , Jan; D'Ambrosio, L., Tadolini, M., Centis, R., Migliori, G.B., A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium (2015) J Thorac Dis, 7 (7), pp. 1080-1085. , Jul; Esposito, S., D'Ambrosio, L., Tadolini, M., Schaaf, H.S., Caminero Luna, J., Marais, B., ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use (2014) ERJ, 44 (3), pp. 811-815. , Sep; Tadolini, M., Garcia-Prats, A.J., D'Ambrosio, L., Hewison, C., Centis, R., Schaaf, H.S., Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges (2016) Eur Respir J, 48 (3), pp. 938-943. , Sep; Tadolini, M., Lingtsang, R.D., Tiberi, S., Enwerem, M., D'Ambrosio, L., Sadutshang, T.D., First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline (2016) Eur Respir J, 48 (3), pp. 935-938. , Sep",
year = "2016",
doi = "10.1016/j.tmaid.2016.11.017",
language = "English",
volume = "14",
pages = "588--590",
journal = "Travel Medicine and Infectious Disease",
issn = "1477-8939",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe

AU - Matteelli, A.

AU - Centis, R.

AU - Sulis, Giorgia

AU - Tadolini, M.

N1 - Export Date: 14 March 2017 CODEN: TMIDA Correspondence Address: Matteelli, A.; Clinic of Infectious and Tropical Diseases, University of BresciaItaly; email: alberto.matteelli@unibs.it References: United Nations, Department of Economic and Social Affairs, Population Division, International migration report 2015: highlights (ST/ESA/SER.A/375) (2016), http://www.un.org/en/development/desa/population/migration/publications/migrationreport/docs/MigrationReport2015_Highlights.pdf, Available at: Accessed on 27 November 2016http://apps.who.int/iris/bitstream/10665/23533/1/A61_R17-en.pdf, World Health Assembly. Resolution WHA61.17 on the Health of Migrants, 24 May 2008. Available at: Accessed on 27 November 2016World Health Organization Global tuberculosis report, World health organization 2016 (2016), WHO/HTM/TB/2016.13 Geneva(2016) Tuberculosis surveillance and monitoring in Europe 2016, , European Centre for Disease Prevention and Control/WHO Regional office for Europe Stockholm; Falzon, D., Mirzayev, F., Wares, F., Baena, I.G., Zignol, M., Linh, N., Multidrug-resistant tuberculosis around the world: what progress has been made? (2015) Eur Respir J, 45, pp. 150-160; Jenkins, H.E., Crudu, V., Soltan, V., Ciobanu, A., Domente, L., Cohen, T., High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova (2014) Eur Respir J, 43, pp. 1132-1141; Hargreaves, S., Lönnroth, K., Nellums, L.B., Olaru, I.D., Nathavitharana, R.R., Norredam, M., Multidrug-resistant tuberculosis and migration to Europe (2016) Clin Microbiol Infect, , Sep 23; Lönnroth, K., Migliori, G.B., Abubakar, I., D'Ambrosio, L., De Vries, G., Diel, T., Towards tuberculosis elimination: an action framework for low-incidence countries (2015) Eur Respir J, 45, pp. 928-952; Pareek, M., Greenaway, C., Noori, T., Munoz, J., Zenner, D., The impact of migration on tuberculosis epidemiology and control in high-income countries: a review (2016) BMC Med, 14, p. 48; Dahle, U.R., Eldholm, V., Winje, B.A., Mannsåker, T., Heldal, E., Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country (2007) Am J Respir Crit Care Med, 176, pp. 930-935; Bernard, C., Brossier, F., Sougakoff, W., Veziris, N., Frechet-Jachym, M., Metivier, N., A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union (2013) Euro Surveill, 18 (33), p. 20555; Noeske, J., Foe, J.L., Kuaban, C., Cameroon's MDR-TB treatment programme jeopardised by cross-border migration (2016) Eur Respir J, 47 (2), pp. 684-686; Liu, Y., Painter, J.A., Posey, D.L., Cain, K.P., Weinberg, M.S., Maloney, S.A., Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States (2012) PLoS One, 7 (2), p. e32158; Codecasa, L.R., Ciconali, G., Mazzola, E., Ferrarese, M., Cirillo, D., Borroni, E., Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal (2015) Eur Respir J, 45, pp. 292-294; Matteelli, A., Lönnroth, K., Mosca, D., Getahun, H., Centis, R., D'Ambrosio, L., Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration (2016) EurRespir J, 47, pp. 686-688; Dara, M., Solovic, I., Goletti, D., Sotgiu, G., Centis, R., D'Ambrosio, L., Preventing and controlling tuberculosis among refugees in Europe: more is needed (2016) Eur Respir J, 48, pp. 272-274; Dara, M., de Colombani, P., Petrova-Benedict, R., Centis, R., Zellweger, J.P., Sandgren, A., Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement (2012) Eur Respir J, 40, pp. 1081-1090; D'Ambrosio, L., Tadolini, M., Centis, R., Duarte, R., Sotgiu, G., Aliberti, S., Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium (2015) Int J Infect Dis, 32, pp. 156-160; D'Ambrosio, L., Tadolini, M., Dupasquier, S., Tiberi, S., Centis, R., Dara, M., ERS/WHO Tuberculosis Consilium: reporting of the initial 10 cases (2014) Eur Respir J, 43 (1), pp. 286-289. , Jan; D'Ambrosio, L., Tadolini, M., Centis, R., Migliori, G.B., A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium (2015) J Thorac Dis, 7 (7), pp. 1080-1085. , Jul; Esposito, S., D'Ambrosio, L., Tadolini, M., Schaaf, H.S., Caminero Luna, J., Marais, B., ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use (2014) ERJ, 44 (3), pp. 811-815. , Sep; Tadolini, M., Garcia-Prats, A.J., D'Ambrosio, L., Hewison, C., Centis, R., Schaaf, H.S., Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges (2016) Eur Respir J, 48 (3), pp. 938-943. , Sep; Tadolini, M., Lingtsang, R.D., Tiberi, S., Enwerem, M., D'Ambrosio, L., Sadutshang, T.D., First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline (2016) Eur Respir J, 48 (3), pp. 935-938. , Sep

PY - 2016

Y1 - 2016

N2 - The number of international migrants worldwide has continued to grow rapidly over the past fifteen years and the trend is expected to continue, making the health matters associated with migration a crucial public health challenges faced by governments and societies. Multidrug-resistant tuberculosis is a paradigm of transmissible diseases that do not respect borders and poses a multifaceted and complex challenge on migrant health. The guiding principles for the health response are the respect of equity and human rights as well as the accurate analysis of epidemiological trends and determinants of TB in migrants. The action framework “Towards tuberculosis elimination: an action framework for low-incidence countries” includes regulations for cross border migration among the top eight interventions for TB elimination in low incidence countries. Political commitment is the essential requirement, and currently, the limiting factor, to draft regulations for cross-border collaboration, establish cross-border referral systems with contact tracing and information sharing. The e-platform TB Consilium hosted by European Respiratory Society in collaboration with World Health Organization – Euro is an example of a tool that can be used to exchange information for clinical management and surveillance. © 2016

AB - The number of international migrants worldwide has continued to grow rapidly over the past fifteen years and the trend is expected to continue, making the health matters associated with migration a crucial public health challenges faced by governments and societies. Multidrug-resistant tuberculosis is a paradigm of transmissible diseases that do not respect borders and poses a multifaceted and complex challenge on migrant health. The guiding principles for the health response are the respect of equity and human rights as well as the accurate analysis of epidemiological trends and determinants of TB in migrants. The action framework “Towards tuberculosis elimination: an action framework for low-incidence countries” includes regulations for cross border migration among the top eight interventions for TB elimination in low incidence countries. Political commitment is the essential requirement, and currently, the limiting factor, to draft regulations for cross-border collaboration, establish cross-border referral systems with contact tracing and information sharing. The e-platform TB Consilium hosted by European Respiratory Society in collaboration with World Health Organization – Euro is an example of a tool that can be used to exchange information for clinical management and surveillance. © 2016

U2 - 10.1016/j.tmaid.2016.11.017

DO - 10.1016/j.tmaid.2016.11.017

M3 - Article

VL - 14

SP - 588

EP - 590

JO - Travel Medicine and Infectious Disease

JF - Travel Medicine and Infectious Disease

SN - 1477-8939

IS - 6

ER -